HIF1A and cancer: In human cancer cells, Metformin decreases cell proliferation in the presence of glucose and reduces hypoxic activation of HIF-1, but increases cell death upon glucose deprivation, indicating that cancer cells rely exclusively on glycolysis for survival in the presence of Metformin (306).